Sutro Biopharma (NASDAQ:STRO) Rating Reiterated by Wedbush
Sutro Biopharma (NASDAQ:STRO – Get Free Report)‘s stock had its “outperform” rating restated by analysts at Wedbush in a research report issued on Tuesday, Benzinga reports. They presently have a $8.00 price target on the stock. Wedbush’s target price suggests a potential upside of 103.56% from the stock’s previous close. Several other equities analysts have […]
More Stories
Comparing SK Growth Opportunities (SKGR) and Its Rivals
Volatility and Risk SK Growth Opportunities has a beta of 0.02, suggesting that its stock price is 98% less volatile...
Mark W. Jenkins Sells 10,000 Shares of Carvana Co. (NYSE:CVNA) Stock
Carvana Co. (NYSE:CVNA – Get Free Report) CFO Mark W. Jenkins sold 10,000 shares of the firm’s stock in a...
Uber Technologies, Inc. (NYSE:UBER) Receives Consensus Rating of “Moderate Buy” from Analysts
Uber Technologies, Inc. (NYSE:UBER – Get Free Report) has received a consensus rating of “Moderate Buy” from the thirty-nine research...
Clean Harbors, Inc. (NYSE:CLH) Given Average Rating of “Buy” by Brokerages
Clean Harbors, Inc. (NYSE:CLH – Get Free Report) has been assigned a consensus rating of “Buy” from the nine brokerages...
Mark Lin Sells 1,359 Shares of Semtech Co. (NASDAQ:SMTC) Stock
Semtech Co. (NASDAQ:SMTC – Get Free Report) CFO Mark Lin sold 1,359 shares of the business’s stock in a transaction...
Insider Selling: Vecima Networks Inc. (TSE:VCM) Senior Officer Sells 800 Shares of Stock
Vecima Networks Inc. (TSE:VCM – Get Free Report) Senior Officer Clay Mccreery sold 800 shares of the firm’s stock in...